Geron to implant embryonic stem cells into humans

Geron Corp., a California-based biotech company, has been given the OK to implant embryonic stem cells in eight to 10 paraplegic patients who can use their arms but can't walk. Stem cell injections will be given within two weeks of the injury. The study will begin this summer, and will be conducted at up to seven different medical centers.

This is the same Geron that discovered TA-65. Geron is reportedly also working on other telomerase activators.